ERBB2 and breast cancer: We observed a significant adverse association among women reporting ever taking siestas and breast cancer risk, which strengthened among those reporting siestas of greater frequency or duration, as well as for triple-negative disease (ER−, PR− and HER2−), though numbers of women here were small.